# Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women

> **NCT01749566** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 31 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** maraviroc

## Key facts

- **NCT ID:** NCT01749566
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2015-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01749566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01749566, "Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01749566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*